Clinical Trial

Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial

Study acronym: PERMEPSY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to compare the efficacy of classical Metacognitive Training (MCT) and personalized Metacognitive Training (P-MCT) for individuals with psychosis. MCT is a psychoeducational program derived from cognitive-behavioral therapy (CBT) that targets cognitive biases associated with psychotic symptoms. The goal is to assess which intervention is more effective to improve the overall functioning of individuals with psychosis. The study will use machine learning to personalize the treatment approach and evaluate its impact on clinical symptoms, cognitive functions, and quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-25.
Trial Details
NCT Number NCT07146802
Lead Sponsor University Hospital, Strasbourg, France
Conditions Schizophrenia Spectrum Disorder
Enrollment 51 participants
Start Date 2025-10-01
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-15